NDC 61958-2501-01 - Biktarvy

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
61958-2501
Requested NDC
61958-2501-01
Package NDCs from labels
61958-2501-1, 61958-2501-2, 61958-2501-3, 61958-2501-5, 61958-2501-01
Manufacturer
Gilead Sciences, Inc.
Effective date
2026-09-09
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Biktarvy - Gilead Sciences, Inc.Gilead Sciences, Inc.2026-09-09HUMAN PRESCRIPTION DRUG LABEL
Biktarvy - REMEDYREPACK INC.REMEDYREPACK INC.2025-01-15HUMAN PRESCRIPTION DRUG LABEL
Biktarvy - A-S Medication SolutionsA-S Medication Solutions2024-04-30HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDCRelated label
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-1These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018
61958-2501-2These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
61958-2501-1Biktarvy30 in 1 BOTTLE, PLASTICTABLET3024
61958-2501-2Biktarvy7 in 1 BOTTLE, PLASTICTABLET724
61958-2501-3Biktarvy30 in 1 BLISTER PACKTABLET3024
61958-2501-5Biktarvy30 in 1 BLISTER PACKTABLET3024

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
61958-2501BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [GILEAD SCIENCES, INC.]20Current NDC, Legacy NDC, 4 package rows20241024_664cb8f0-1f65-441b-b0d9-ba3d798be309.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
61958-2501-1EA - Each61958-25016aa39ee3-3afc-4ca2-b2e0-a3fdd44e9b2212018-03-08
61958-2501-3EA - Each61958-25013e8532ff-f9f4-48b0-b2b2-8bb1eece913a12021-06-02

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 119 · 2,378 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREENOCTINOXATE AND TITANIUM DIOXIDESICOS ET CIEa8dd72b4-0c04-4cca-a188-c60d5e4785a22026-09-25WarningsExact identifier
unii: 15FIX9V2JP
LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREENOCTINOXATE AND TITANIUM DIOXIDEL'Oreal USA Products Inc5b101ba5-65bd-8c1e-e063-6294a90ab98e2026-09-25WarningsExact identifier
unii: 15FIX9V2JP
LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREENOCTINOXATE AND TITANIUM DIOXIDESICOS ET CIE5b106520-651d-d5f8-e063-6294a90a04122026-09-25WarningsExact identifier
unii: 15FIX9V2JP
Calamine Plus Pramoxine HClCALAMINE PLUS SPRAYTopco Associates LLCaf314adb-bd65-4233-b7e1-6cfb819615a32026-09-25WarningsExact identifier
unii: 1K09F3G675
Calamine Plus Pramoxine HClCALAMINE PLUS NO-TOUCHWalgreens Company33219878-f102-46c6-bd63-e83d54fa27852026-09-25WarningsExact identifier
unii: 1K09F3G675
BANANA BABYTITANIUM DIOXIDE,ZINC OXIDEEdgewell Personal Care Brands LLC5c3ea09e-8bf0-7873-e063-6294a90a3fd32026-09-24WarningsExact identifier
unii: 15FIX9V2JP
Rugby Eye WashWATER, PURIFIEDRugby Laboratories1fee974b-4c29-4965-bd3d-da5e219eb13a2026-09-24WarningsExact identifier
unii: 059QF0KO0R
Yellow, Orange, Red Tinted SPF 50 Sunscreen Zinc SticksRED ZINC STICKStandard Procedure Inc49f831ad-e87a-0ec7-e063-6294a90a9d0e2026-09-23WarningsExact identifier
unii: 15FIX9V2JP
Tan Zinc Stick SPF 50TAN ZIN STICK SPF 50Standard Procedure Inc49f94669-cadf-fbbd-e063-6394a90a48fa2026-09-23WarningsExact identifier
unii: 15FIX9V2JP
ZO Skin Health Daily Mineral Sunshade Broad-Spectrum Sunscreen SPF 50 (Fair)TITANIUM DIOXIDE, ZINC OXIDEZO Skin Health Inc.4f81e482-8111-451c-e063-6294a90ad1482026-09-22WarningsExact identifier
unii: 15FIX9V2JP
CalamineCALAMINE, PRAMOXIND HCLNice-Pak Products, LLC9089e23e-ca4a-454f-8dcc-ff5a29a5a3352026-09-22Warnings, Adverse reactionsExact identifier
unii: 1K09F3G675
Sterile WaterWATERB. Braun Medical Inc.f4284eb6-e553-46d4-90d8-efc80a90a4802026-09-18Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
Juyasuyon CONCEALER SUNSCREENOCTINOXATE,OCTOCRYLENE,TITANIUM DIOXIDE,OCTISALATE,BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINEGuangdong Aimu Biological Technology Co., Ltd5a567960-b083-b17d-e063-6394a90ac6d72026-09-18WarningsExact identifier
unii: 15FIX9V2JP
BANANA BOATTITANIUM DIOXIDE,ZINC OXIDEEdgewell Personal Care Brands LLC5b9a32ab-4ab7-475d-e063-6294a90a49ba2026-09-16WarningsExact identifier
unii: 15FIX9V2JP
REFRESH ClassicPOLYVINYL ALCOHOL, POVIDONEAllergan, Inc.31bf1d6c-9719-4060-b6a3-409a2fe7b5602026-09-15WarningsExact identifier
unii: 532B59J990
CalamineCALAMINE, ZINC OXIDENice-Pak Products, LLCc370ee1f-1887-44e8-8d47-8ffa3c270ff52026-09-15Warnings, Adverse reactionsExact identifier
unii: 1K09F3G675
Natural SPF 30TITANIUM DIOXIDE, ZINC OXIDESpa de Soleil4ebe65c3-c1b9-3496-e054-00144ff88e882026-09-15WarningsExact identifier
unii: 15FIX9V2JP
Natural SPF 50TITANIUM DIOXIDE, ZINC OXIDESpa de Soleil4eb87d1e-601a-1209-e054-00144ff8d46c2026-09-15WarningsExact identifier
unii: 15FIX9V2JP
FlyLeaf RINGWORM TREATMENTMICONAZOLE NITRATE 2%Guangzhou Huixue Biotechnology Co., Ltd.5b597a3b-b5ff-2246-e063-6394a90a10462026-09-13WarningsExact identifier
unii: 059QF0KO0R
MISSHA M Perfect Cover BB No.23OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDEAble C&C Co., Ltd.49fb7346-b7f5-4ba8-e063-6294a90a2cf52026-09-11WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.